140 related articles for article (PubMed ID: 38058077)
1. Construction of a Nomogram Model to Identify Atherosclerotic Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus.
Sun H; Men C; Deng H; Wang C; Li R; Sun Y; Yang H; Wu M; Zheng W; Zhan Y
Discov Med; 2023 Dec; 35(179):1114-1122. PubMed ID: 38058077
[TBL] [Abstract][Full Text] [Related]
2. Normal-weight visceral obesity promotes a higher 10-year atherosclerotic cardiovascular disease risk in patients with type 2 diabetes mellitus-a multicenter study in China.
Zheng J; Hu Y; Xu H; Lei Y; Zhang J; Zheng Q; Li L; Tu W; Chen R; Guo Q; Zang X; You Q; Xu Z; Zhou Q; Wu X
Cardiovasc Diabetol; 2023 Jun; 22(1):137. PubMed ID: 37308932
[TBL] [Abstract][Full Text] [Related]
3. Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies.
Ray KK; Del Prato S; Müller-Wieland D; Cariou B; Colhoun HM; Tinahones FJ; Domenger C; Letierce A; Mandel J; Samuel R; Bujas-Bobanovic M; Leiter LA
Cardiovasc Diabetol; 2019 Nov; 18(1):149. PubMed ID: 31706300
[TBL] [Abstract][Full Text] [Related]
4. Nomogram Prediction for the Risk of Diabetic Foot in Patients With Type 2 Diabetes Mellitus.
Wang J; Xue T; Li H; Guo S
Front Endocrinol (Lausanne); 2022; 13():890057. PubMed ID: 35909507
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a novel 10-year cardiovascular risk prediction nomogram for the United Arab Emirates national population.
Al-Shamsi S
BMJ Open; 2022 Dec; 12(12):e064502. PubMed ID: 36581433
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a nomogram to predict the risk of peripheral artery disease in patients with type 2 diabetes mellitus.
Liang J; Song J; Sun T; Zhang L; Xu S
Front Endocrinol (Lausanne); 2022; 13():1059753. PubMed ID: 36578962
[TBL] [Abstract][Full Text] [Related]
7. Predictive nomogram model for major adverse kidney events within 30 days in sepsis patients with type 2 diabetes mellitus.
Xin Q; Xie T; Chen R; Wang H; Zhang X; Wang S; Liu C; Zhang J
Front Endocrinol (Lausanne); 2022; 13():1024500. PubMed ID: 36589822
[TBL] [Abstract][Full Text] [Related]
8. Novel model predicts diastolic cardiac dysfunction in type 2 diabetes.
Hao M; Huang X; Liu X; Fang X; Li H; Lv L; Zhou L; Guo T; Yan D
Ann Med; 2023 Dec; 55(1):766-777. PubMed ID: 36908240
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a nomogram model for individualized prediction of hypertension risk in patients with type 2 diabetes mellitus.
Yang J; Wang X; Jiang S
Sci Rep; 2023 Jan; 13(1):1298. PubMed ID: 36690699
[TBL] [Abstract][Full Text] [Related]
10. A simple nomogram score for screening patients with type 2 diabetes to detect those with hypertension: A cross-sectional study based on a large community survey in China.
Xue M; Liu L; Wang S; Su Y; Lv K; Zhang M; Yao H
PLoS One; 2020; 15(8):e0236957. PubMed ID: 32764769
[TBL] [Abstract][Full Text] [Related]
11. [Establishment and Evaluation of a Nomogram Prediction Model for the Risks of Nontraumatic Fracture in Older Adults with Type 2 Diabetes Mellitus].
Tian Y; Dong QJ; Li L; Fan HJ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Jan; 54(1):176-180. PubMed ID: 36647663
[TBL] [Abstract][Full Text] [Related]
12. Development and External Validation of Nomogram to Identify Risk Factors for CHD in T2DM in the Population of Northwestern China.
Meng Q; Yang J; Wang F; Li C; Sang G; Liu H; Shen D; Zhang J; Jiang S; Yusufu A; Du G
Diabetes Metab Syndr Obes; 2023; 16():1271-1282. PubMed ID: 37168834
[TBL] [Abstract][Full Text] [Related]
13. Construction and validation of a nomogram for predicting diabetes remission at 3 months after bariatric surgery in patients with obesity combined with type 2 diabetes mellitus.
Yuan K; Wu B; Zeng R; Zhou F; Hu R; Wang C
Diabetes Obes Metab; 2024 Jan; 26(1):169-179. PubMed ID: 37807830
[TBL] [Abstract][Full Text] [Related]
14. Atherosclerotic Cardiovascular Disease in Diabetes Patients.
Amelia R; Sari Wahyuni A; Yunanda Y; Wijaya H
Curr Diabetes Rev; 2023; 19(8):e060223213457. PubMed ID: 36748224
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a risk nomogram model for predicting peripheral neuropathy in patients with type 2 diabetes mellitus.
Luo L; Long X; Cheng C; Xu Q; Li J
Front Endocrinol (Lausanne); 2024; 15():1338167. PubMed ID: 38742191
[TBL] [Abstract][Full Text] [Related]
16. Age-Related Associations of Low-Density Lipoprotein Cholesterol and Atherosclerotic Cardiovascular Disease: A Nationwide Population-Based Cohort Study.
Jung HN; Kim MJ; Kim HS; Lee WJ; Min SH; Kim YJ; Jung CH
J Am Heart Assoc; 2022 May; 11(9):e024637. PubMed ID: 35492003
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a nomogram for evaluating the incident risk of carotid atherosclerosis in patients with type 2 diabetes.
Feng X; Ren L; Xiang Y; Xu Y
Front Endocrinol (Lausanne); 2023; 14():1131430. PubMed ID: 36875469
[TBL] [Abstract][Full Text] [Related]
18. Establishment and validation of prediction model for atherosclerotic cardiovascular disease in patients with hyperuricemia.
Du X; Chen F; He Y; Zou H; Pan H; Zhu X
Int J Rheum Dis; 2024 Jun; 27(6):e15205. PubMed ID: 38873791
[TBL] [Abstract][Full Text] [Related]
19. Nomogram model and risk score to predict 5-year risk of progression from prediabetes to diabetes in Chinese adults: Development and validation of a novel model.
Han Y; Hu H; Liu Y; Wang Z; Liu D
Diabetes Obes Metab; 2023 Mar; 25(3):675-687. PubMed ID: 36321466
[TBL] [Abstract][Full Text] [Related]
20. A new nomogram model for the individualized prediction of mild cognitive impairment in elderly patients with type 2 diabetes mellitus.
Jiang Y; Liu X; Gao H; Yan J; Cao Y
Front Endocrinol (Lausanne); 2024; 15():1307837. PubMed ID: 38654929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
